Uncategorized

How Brand-Name Drug Companies Delay Generic Competition: Product Hopping, Patent Thickets, and Market Exclusivity Tactics Explained

🚨 Generic competition isnt just late. Often, its engineered.
In the life sciences world, timing is everything: patent cliffs decide whether costs drop for patientsor stay high. And while the public conversation typically frames delays as inevitabl…

How Brand-Name Drug Companies Delay Generic Competition: Product Hopping, Patent Thickets, and Market Exclusivity Tactics Explained Read Post »

Biotechblog
Scroll to Top